This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gottlin, E. B. Articles by Christensen, D. J. Search for Related Content PubMed PubMed Citation Articles by Gottlin, E. B. Articles by Christensen, D. J. Social Bookmarking                         What's this?

High-Throughput Screen for Inhibitors of 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase by Surrogate Ligand Competition

R. Edward Benson

Scott Conary

Karo Bio USA, Inc., Durham, NC.

Brett Antonio

Icagen, Inc., Durham, NC.

Kellie Duke

E. Sturgis Payne

S. Salman Ashraf

Karo Bio USA, Inc., Durham, NC.

Dale J. Christensen

Aryzun Pharmaceuticals, Raleigh, NC. dale.christensen{at}aryzum.com

1-Deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr) is a key enzyme in a biosynthetic pathway for isoprenoids that is unique to eubacteria and plants. Dxr catalyzes the rearrangement and NADPH-dependent reduction of 1-deoxy-D-xylulose 5-phosphate to 2-C-methyl-D-erythritol 4-phosphate. The authors have purified Escherichia coli Dxr and devised a high-throughput screen (HTS) for compounds that bind to this enzyme at a functional site. Evidence is presented that the surrogate ligand directly binds or allosterically affects both the D-1-deoxyxylulose 5-phosphate (DXP) and NADPH binding sites. Compounds that bind at either or both sites that compete for binding with the surrogate ligand register as hits. The time-resolved fluorescence-based assay represents an improvement over the Dxr enzyme assay that relies on relatively insensitive measurements of NADPH oxidation. Screening 32,000 compounds from a diverse historical library, the authors obtained 89 potent inhibitors in the surrogate ligand competition assay. The results presented here suggest that peptide surrogate ligands may be useful in formatting HTS for proteins with difficult biochemical assays or targets of unknown function. (Journal of Biomolecular Screening 2003:332-339)

Key Words: high-throughput screening • Dxr • ligand-binding assays • DXP and NADPH binding sites • fosmidomycim

Journal of Biomolecular Screening, Vol. 8, No. 3, 332-339 (2003)
DOI: 10.1177/1087057103008003011


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?